Want to read Slashdot from your mobile device? Point it at m.slashdot.org and keep reading!


Forgot your password?
DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Also, Slashdot's Facebook page has a chat bot now. Message it for stories and more. Check out the new SourceForge HTML5 Internet speed test! ×

Comment Re:There is already enough material (Score 4, Informative) 153

Technically, you're correct. However, the coverage the protests received from Big Media are also copyrighted to Big Media, which puts it outside the financial range of individuals who want to use that coverage without paying for very expensive per-item licensing fees.

For example, I'm personally aware that the University of Kentucky archives contacted CBS to get a 6 minute video clip of their basketball team in action from 1998 to include within a larger documentary about UK's sports history. CBS said it would cost about $10,000 for that one clip. The story's the same for other copyrighted history like the 1979 Who tragedy in Cincinnati, Martin Luther King's "I Have a Dream" speech, and countless other historical events.

The NYU archivists know this, and it's why they can't count on Big Media - they have to do it themselves.

Comment Re:need much better pay to motivate jury $17 a day (Score 1) 405

I understand your sentiment, but good luck with that fairy tale you've suggested.

Enough Americans are now obsessed enough about taxes that the tax increase needed to pay for your Increased Jury Pay suggestion would get hammered at the ballot.

However, if you suggested lowering jury pay to help some taxhole save $0.12 on his bill, I'm pretty sure it would pass.

Comment Overblown Response (Score 2) 464

Wow, interesting early comments. I remember the Pentagon Papers release (their release caused Nixon to go into a paranoid overdrive that resulted in Watergate) and the blowback it caused due to the government's lies.

Frankly, the more secrets they release, the more transparent national leaders' lies will be to the public. That's not to say that's good or bad, it just is.

As for being a traitor to America or Russia or the banking system, riiiiiight.


Submission + - Smart roads set to get smarter in Australia (zdnet.com.au)

lukehopewell1 writes: Queensland Motorways plans to lead the charge towards building smarter networks, with chairman David Gray saying that collaboration between stakeholders is crucial.

At an IBM roundtable event yesterday, Gray recounted the three-year, $2 billion free-flow tolling upgrade: an intelligent system that has replaced manual toll collection which, according to Gray, is set to get smarter in the coming years.

"The investment in this free-flow tolling is part of a journey. It's got video tagging and laser designation of vehicles. We can use three or four different forms of recognising a vehicle. Our system...can just as easily recognise your number plate [via laser reading] as a[n e-tag] could designate a vehicle," Gray said.

Queensland Motorways is looking to implement a "system of systems" to better manage these new technological advances, said Gray.

"My perception of the reason why stakeholders don't get engaged in a system-of-systems way of doing things, is the idea that there's going to be a winner and a loser [in the deal] — that's not true," he said.

"Take our network, for example, there are a number of feeder roads run by Brisbane City Council and the motorways themselves are run by Queensland Motorways. If there's an issue on the Brisbane City network, there will be an issue on our network and vice versa."

"The mindset of a win-win is absolutely critical to system-of-systems thinking."

Gray wants to move in a direction where the Queensland road network can be interconnected to automate and better manage traffic lights, signposts, public announcements, speed zones and the gathering of traffic information and statistics.


Submission + - Aussie schools go wild for the iPad (delimiter.com.au)

An anonymous reader writes: Looks like it's not just Apple fanboys that are going wild for the iPad ... in Australia, virtually every state education department is trialling the tablet in schools — and some schools are even trialling it without the official support of their department. One university in Adelaide has even abolished textbooks for first year science students and is allocating free iPads to first year students instead. It will be interesting to see what happens when the inevitable wave of Android tablets hits over the next six months.

Submission + - Competitor threatens suit - counter DMCA takedown?

An anonymous reader writes: Zen Magnets, a maker of neodymium magnets, has been under assault by the much larger and better distributed Buckyballs, a maker of a nearly identical toy. After Zen Magnets listed a couple of eBay auctions with a set of Buckyballs and a set of their own, asking customers to decide which was higher quality, Buckyballs replied with a legal threat. Zen Magnets responded with an open video response, in which they presented the voicemail from Buckyballs and demonstrated their claims of quality through repeatable, factual tests, providing quantitative data to back up their assertions.

Soon after, Buckyballs CEO Jake Bronstein got the video taken down from Youtube via a DMCA takedown, despite the fact that the only elements not made by Zen Magnets are the voicemail he left and some images of himself, which are low resolution and publicly available online.

Zen Magnets is now asking for help as they don't know what to do. It's appalling and I can't imagine that it is infringing, but I am not a lawyer. What would you do in this scenario?

(I am affiliated with neither company, although Thinkgeek sells Buckyballs...Slashdot & ThinkGeek share a corporate overlord.)

Submission + - Unknown Facts About Alzheimers

An anonymous reader writes: I follow the progress of research with Alzheimer’s, Parkinson’s and ALS on a daily basis. I have a close friend or family member that has been affected by each of those diseases. What puzzles me is that no one can diagnose these diseases until they have reached a late stage and by then it’s too late. Over the past few years I have seen numerous press releases of researchers and companies coming up with treatments and tests, but none of them seem to work out and the diseases just keep hitting more and more people. Just today it was announced that “globally the cost of caring for people with dementia has been forecast at $637 billion this year. Estimated there were now 35.6 million people living with dementia globally, and the cost of their care and associated impacts would account for one per cent of global GDP this year. About 70 per cent of these costs occur in Western Europe and North America, despite nearly two-thirds of people with dementia living in low and middle income countries.”
One expert said that until there is a test to identify Alzheimer’s at an early stage, very little would be done in regards to treatments. The science is stuck in one place and no-one can seem to get past this barrier and onto the next stage which would bring this disease closer to understanding and treated.
Unknown to almost everyone, is a team of Canadian researchers that are very close to breaking that barrier. I have been following this company for about 5 years now and I have been able to get to know some of the researchers and company officials quite well. One thing that I have realized is that they are quietly working at a number of products that will very shortly be the standard relating to diagnostics and therapeutics. While many researchers and biotech are coming out with claims at very preliminary stages, this company does not reveal anything till the science is completed. Here are a few highlights on the company’s progress which really emphasise how close they are.

About Amorfix

Amorfix Life Sciences Ltd. (TSX:AMF) is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including Alzheimer’s disease, ALS, and cancer. The Company’s diagnostic programs include an ultrasensitive method for the detection of aggregated Beta-Amyloid in brain tissue and blood from animal models of AD, months prior to observable amyloid formation, as well as human blood screening tests for Alzheimer’s and early liver cancer detection. Amorfix’s proprietary Epitope Protection (EP) technology enables it to specifically identify very low levels of aggregated misfolded proteins (AMP) in a sample. Amorfix utilizes its computational discovery platform, ProMIS, to predict novel Disease Specific Epitopes (“DSE”) on the molecular surface of misfolded proteins. Amorfix’s lead therapeutic programs include antibodies and vaccines to DSEs in ALS, AD and cancer. For more information about Amorfix, visit www.amorfix.com.

Press Releases:
Amorfix Life Sciences announces world's first detection of aggregated beta-amyloid in blood using the Alzheimer's diagnostic A4 Assay (May 4, 2010)Amorfix Life Sciences Ltd. announced today the detection of the AD-associated aggregated Beta-amyloid (ABeta), the hallmark of AD, in the blood from the most-frequently-used animal model of AD.

Amorfix and reMYND announces testing service agreement for the A4 Alzheimer's Test, July 6, 2010

Amorfix A4 Assay Provides New Insights Into Alzheimer's Disease Pre-Clinical Development Mouse Models , July 12, 2010

Amorfix Life Sciences Announces Publication of A4 Data in Prestigious Journal of Alzheimer's Disease and Provides Update on Management Changes, September 16, 2010

About A4
The Amorfix A4 assay is an ultrasensitive method for the detection of aggregated Abeta that provides quantitative measurements of aggregates. The A4 can detect aggregates in plasma, and brain tissue from standard animal models of AD several months before conventional microscopic procedures thereby accelerating the preclinical screening of new drugs for AD. The A4 is significantly more sensitive than current methods for detecting total Abeta and can be used in high-throughput applications designed to study the inhibition of amyloid formation.

Alzheimer's Disease Diagnostics — from Robert Gundel, PhD, MBA, President and CEO
We are continuing with A4 assay optimization and development for use as a human diagnostic. We are on track and expect to have all feasibility studies completed by year end. The recent publication of the results from an ADNI sponsored study that examined the usefulness of measurements of A and tau in the cerebrospinal fluid (CSF) for predicting progression to Alzheimer's disease is of particular importance to Amorfix. This report solidified the diagnostic importance of measuring specific biochemical markers in CSF and confirms the value of CSF measurements in predicting Alzheimer's diseases. Amorfix is encouraged by these data, and our plan is to have the A4 assay included in predictive clinical diagnosis of Alzheimer's disease in the future. As you know, this is an immense market opportunity as there are currently no available biochemical assays for the accurate diagnosis of Alzheimer's disease.
The Liver Cancer Diagnostic program and our Cancer Antibody Programs are all moving forward on budget and on schedule. I will be providing updates on these programs when significant milestones are reached.
Amorfix continues to focus on several fronts to ensure that our product pipeline of novel diagnostics and therapeutics are successful. I will keep you updated on a regular basis on our scientific and business accomplishments throughout the year.

The researchers use AD infected mice to test their AD anti-bodies. This is a controlled experiment as they know the mice have AD. The next stage of research is to be able to locate amyloids in dogs. Did you know that certain breeds of dogs develop dementia naturally and it mirrors human AD? Guess what the company has developed its A4 test to locate AD in dogs. Many of us do not think that they will announce this until they are closer to attending the Canine Cognition, Aging and Neuropathology Conference, 11-12 November 2010: Laguna Beach, CA, USA.
The company is also involved in research in Parkinson’s, ALS, vCjd, BSE and 4-5 different cancers with a number of various partners. The offshoot of this company is other research organizations that involve Dr Neil Cashman ( PrioNet and Prevent). But There are people that are are aware and watching this company very closely , a few HUGE pharamacutical companies I think it would be a great story that would bring peoples hopes up that there are companies that are much closer to the answer then many think.

Len H
Edmonton Alberta Canada

Submission + - Evercookie - the virtually unrevocable browser coo (samy.pl) 1

Siteriver writes: Samy Kamkar releases a javascript-based API and working code that appears to provide uber-persistent storage by storing the cookie data in several types of storage mechanisms, including storing cookies in RGB values of auto-generated, force-cached PNGs, several HTML5 containers, and even a way to store data in the browser history. All wrapped up in a simple PHP/javascript package.

Submission + - Weiskopf's Intellectual Property Law Blog: New Law (blogspot.com)

David Weiskopf writes: Wow — talk about taking the fight to them! Yesterday, NBC Universal, CBS Broadcasting, CW, Disney, Fox, Major League Baseball and other media giants were sued in Federal District Court in the Western District of Washington by start-up ivi, Inc. for declaratory judgment of copyright non-infringement (read Complaint here).

Comment Re:Educational Problems (Score 0, Flamebait) 629

After all, teachers aren't barely-literate manual laborers; they have college degrees - shouldn't they be able to negotiate a salary on their own?

Ah, GOT IT! Flunk out of college, retain the right to collective bargaining. Graduate college, lose the right to collective bargaining. Wow, you're the walking, talking embodiment of someone who received an extraordinarily poor education.

If there were a market in teacher pay, for example, I'm reasonably certain that a high school physics teacher would make a lot more than a kindergarten teacher.

If the high school physics teacher is even a tad competent in their field, they do. It's called consulting. K teachers don't get it, but physics and chemistry teachers can if they want it. Otherwise, I won't bring up the 5-10 issues you're NOT addressing in this zero-sum scenario.

Comment Re:The answer is yes. (Score 2, Interesting) 1093

if they do know more about the topic then answering the skepticism shouldn't be a problem should it?

Answering the skepticism is completely acceptable. Answering the skepticism one skeptic (of millions) at a time, with each skeptic having a different set of skepticism, and frankly not asking in the spirit of education but in cynicism IS A PROBLEM.

Slashdot Top Deals

"You stay here, Audrey -- this is between me and the vegetable!" -- Seymour, from _Little Shop Of Horrors_